Wang Yining, Liu Shiting, Zhang Xinyu, Ma Haifeng, Ying Xiaohua
School of Public Health, Fudan University, Shanghai, China.
Global Health Research Center, Duke Kunshan University, Kunshan, China.
Int J Equity Health. 2025 Mar 19;24(1):78. doi: 10.1186/s12939-025-02447-w.
Variations in hospital costs often indicate deficiency in efficient and standardised care. Case-based provider payment systems are utilised globally to address these issues. In China, an innovative case-based payment scheme called the Diagnosis-Intervention Packet (DIP) under the global budget framework has been progressively implemented. However, evidence regarding its effectiveness and potential mechanisms underlying its impact is limited. This study aimed to investigate the impact of DIP reform on hospital cost variations among patients with cerebral infarction (CI) and to explore potential pathways through quality-cost trade-offs.
This cross-sectional study analysed de-identified discharge records of patients from City G, China, between January 2018 and December 2022. The study included 293,255 cases discharged with CI from 185 hospitals. Interrupted time series models were used to assess the overall and heterogeneous impacts on hospital cost variations, measured by the coefficient of variation (CV) and interquartile range (IQR) of the hospital-level average cost per case. The contribution of each itemised cost was quantified using grey relational analysis. Quality measures were compared across hospital groups organised based on the hospitals' relative cost rankings.
Following the DIP reform, a significant immediate decline of 0.137 (p = 0.031) was observed in the CV. The quarterly trends in CV decreased by 0.001 (p = 0.954) and IQR by 103.40 RMB ($14.48; p = 0.389). Subgroup analyses found significant reductions in secondary hospitals, surgical groups, and medication costs, with medication costs aligning the most with the total change. Given hospital convergence toward the average cost level, no association between costs and quality was observed. Hospitals transitioning from the high-cost category experienced a reduction in in-hospital mortality (-0.5%). Similarly, those moving from the average- to low-cost category demonstrated decreased mortality (-0.7%) and complications (-0.5%).
Our findings revealed a concentrated distribution of post-reform hospital costs without compromising quality. These findings suggest the effectiveness of case-based payment systems in reducing hospital cost variations and improving healthcare efficiency, potentially because providers adopt more standardised behaviours in response to incentive changes. This study offers insights to other countries on payment systems as leverage to achieve efficient, equitable, and high-value care.
医院成本的差异往往表明高效和标准化护理存在不足。基于病例的医疗服务提供者支付系统在全球范围内被用于解决这些问题。在中国,一种创新的基于病例的支付方案,即在全球预算框架下的诊断-干预组合(DIP),已逐步实施。然而,关于其有效性以及潜在影响机制的证据有限。本研究旨在调查DIP改革对脑梗死(CI)患者医院成本差异的影响,并通过质量-成本权衡探索潜在途径。
这项横断面研究分析了2018年1月至2022年12月期间中国G市患者的匿名出院记录。该研究纳入了185家医院的293,255例CI出院病例。采用中断时间序列模型来评估对医院成本差异的总体和异质性影响,以每家医院每例病例的平均成本的变异系数(CV)和四分位距(IQR)来衡量。使用灰色关联分析量化每项明细成本的贡献。根据医院相对成本排名对医院分组,比较各医院组之间的质量指标。
DIP改革后,观察到CV立即显著下降了0.137(p = 0.031)。CV的季度趋势下降了0.001(p = 0.954),IQR下降了103.40元人民币(14.48美元;p = 0.389)。亚组分析发现二级医院、手术组和药品成本有显著降低,其中药品成本与总体变化最为一致。鉴于医院趋向于平均成本水平,未观察到成本与质量之间的关联。从高成本类别转变的医院,住院死亡率有所下降(-0.5%)。同样,那些从平均成本类别转变为低成本类别的医院,死亡率(-0.7%)和并发症(-0.5%)有所下降。
我们的研究结果显示改革后医院成本集中分布且质量未受影响。这些结果表明基于病例的支付系统在降低医院成本差异和提高医疗效率方面是有效的,这可能是因为医疗服务提供者为响应激励变化而采取了更标准化的行为。本研究为其他国家提供了关于支付系统的见解,可作为实现高效、公平和高价值医疗的手段。